Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
QURE
#2169
uniQure N.V.
15.6
3
-9.76%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-9.76%
Monatliche Änderung
-34.90%
6 month change
-1.01%
Jahresänderung
+33.02%
Vorheriger Schlusskurs
17.3
2
Open
15.6
3
Bid
Ask
Low
15.6
3
High
15.6
3
Volumen
137
Märkte
Aktien
Gesundheitswesen
QURE
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
48.74 M
54.08 M
54.75 M
54.87 M
62.29 M
—
Valuation ratios
Enterprise value
-11.32 M
796.07 M
363.11 M
511.07 M
3.04 B
4.71 B
Price to earnings ratio
-1
-3.59
-2.43
-3.59
-13.36
-22.97
Price to sales ratio
8.34
31.68
25.69
49.83
197.14
304.34
Price to cash flow ratio
1.33
4.7
3.17
4.11
19.96
31.94
Price to book ratio
0.47
127.24
2.71
7
12.28
149.22
Enterprise value to EBITDA ratio
0.3
54.59
-9.05
-10.18
-66.77
-31.41
Profitability ratios
Return on assets %
0.07
0.13
0.07
-0.06
-0.09
0.05
Return on equity %
0.8
10.85
1.3
-9.42
-0.35
2.37
Return on invested capital %
-79.67
-94.17
-90.54
-98.03
-90.99
-373.73
Gross margin %
88.46
88.14
87.43
87.53
89.25
352.35
Operating margin %
-1 758.99
-877.76
-2 509.96
-833.62
-1 378.95
-5 600.29
EBITDA margin %
-225.71
-821.74
-191.38
15.91
-12.02
-1 009.24
Net margin %
1 940.45
1 403.2
2 784.75
-716.82
-2 175.87
1 295.26
Liquidity ratios
Quick ratio
6.51
—
—
—
—
—
Current ratio
6.51
9.74
11.99
9.98
7.12
38.84
Inventory turnover
-0.1
—
—
—
—
—
Asset turnover
0
0.01
0
0.01
0.01
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.08
0.09
0.09
0.09
0.06
0.32
Long term debt to total equity ratio
0.92
-7.6
1.53
-12.95
0.23
-18.79
Per share metrics
Operating cash flow per share
-0.75
-1.09
-0.83
-0.73
-0.29
-2.94
EBIT per share
-0.14
-0.93
-0.1
-0.02
-0.04
-1.09
EBITDA per share
-0.11
-0.88
-0.06
0.02
-0.01
-0.93
Total debt per share
—
—
—
—
—
—
Cash per share
8.97
7.56
7.7
6.91
12.42
34.6
Net current asset value per share
9.55
8.02
8.2
7.49
12.82
36.53
Tangible book value per share
-0.92
-0.92
-1.16
-1.92
2.31
-1.69
Working capital per share
8.09
7.2
7.51
6.74
11.02
32.47
Book value per share
1.15
-0.14
0.63
-0.07
4.09
4.52
uniQure N.V
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
Nachrichten
uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)
uniQure-Quartalszahlen: Zulassungsweg für Hoffnungsträger AMT-130 im Fokus
uniQure earnings in focus as AMT-130 regulatory path looms
Stifel bewertet uniQure nach Äußerungen des FDA-Commissioners zu seltenen Krankheiten
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Applied Materials, Broadcom among market cap stock movers on Thursday
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates
UniQure-Aktie bricht nach FDA-Kommentaren zu Gentherapie-Studie ein
UniQure stock tumbles on FDA comments about gene therapy trial
uniQure: Wolfe Research nimmt Bewertung mit „Peerperform“ auf
uniQure stock initiated at Peerperform by Wolfe Research